Edge Wealth Management LLC Novavax Inc Transaction History

Edge Wealth Management LLC

$497 Million
Q3 2024

A detailed history of Edge Wealth Management LLC transactions in Novavax Inc stock. As of the latest transaction made, Edge Wealth Management LLC holds 15,000 shares of NVAX stock, worth $132,300. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,000

Previous 15,000 -0.0%

Holding current value

$132,300

Previous $189,000 -0.0%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$4.8 - $7.67 $7,963 - $12,724	-1,659 Reduced 9.96%	15,000 $72,000
Q4 2022 Jan 25, 2023	SELL	$8.86 - $25.04 $11,881 - $33,578	-1,341 Reduced 7.45%	16,659 $0
Q1 2022 Apr 14, 2022	BUY	$69.73 - $142.9 $139,460 - $285,800	2,000 Added 12.5%	18,000 $1.33 Million
Q4 2021 Jan 14, 2022	BUY	$134.56 - $217.97 $672,800 - $1.09 Million	5,000 Added 45.45%	16,000 $2.29 Million
Q3 2021 Oct 13, 2021	BUY	$177.8 - $270.58 $177,800 - $270,580	1,000 Added 10.0%	11,000 $2.28 Million
Q2 2021 Jul 23, 2021	BUY	$121.0 - $257.67 $847,000 - $1.8 Million	7,000 Added 233.33%	10,000 $2.12 Million
Q1 2021 Apr 09, 2021	SELL	$112.98 - $319.93 $1.36 Million - $3.84 Million	-12,010 Reduced 80.01%	3,000 $544,000
Q4 2020 Jan 19, 2021	BUY	$78.74 - $139.5 $377,164 - $668,205	4,790 Added 46.87%	15,010 $1.68 Million
Q3 2020 Oct 21, 2020	SELL	$79.44 - $178.51 $1.58 Million - $3.56 Million	-19,930 Reduced 66.1%	10,220 $1.11 Million
Q2 2020 Aug 03, 2020	SELL	$13.86 - $83.61 $138 - $836	-10 Reduced 0.03%	30,150 $2.51 Million
Q1 2020 Apr 20, 2020	BUY	$3.93 - $16.0 $109,548 - $446,000	27,875 Added 1219.91%	30,160 $424,000
Q4 2019 Jan 29, 2020	BUY	$3.69 - $5.22 $7,380 - $10,440	2,000 Added 701.75%	2,285 $9,000
Q2 2019 Jul 15, 2019	BUY	$4.93 - $12.2 $1,405 - $3,477	285 New	285 $2,000

Others Institutions Holding NVAX

# of Institutions

291

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $690M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.

Account

Edge Wealth Management LLC Novavax Inc Transaction History